O Kellner

Antimicrobial therapy of unexplained fever in neutropenic patients

Hartmut Link, A. B�hme, Oliver A. Cornely et al. · Annals of Hematology · 2003 · 248 citations

Antibiotics, Healthcare-associated Infection, Sepsis +4

Diagnosis and treatment of documented infections in neutropenic patients

Dieter Buchheidt, Angelika Böhme, Oliver A. Cornely et al. · Annals of Hematology · 2003 · 105 citations

Documented Infections, Healthcare-associated Infection

295 Capecitabine plus irinotecan (CAPIRI) vs capecitabine plus oxaliplatin (CAPOX) as first-line therapy of advanced colorectal cancer (ACRC): updated results of a randomized phase II trial

Axel Grothey, Kim Jordan, O Kellner et al. · European Journal of Cancer Supplements · 2003 · 63 citations

First-line Therapy, Oncology, Gastrointestinal Oncology +10

Capecitabine/ irinotecan (CapIri) and capecitabine/oxaliplatin (CapOx) are active second-line protocols in patients with advanced colorectal cancer (ACRC) after failure of first-line combination therapy: Results of a randomized phase II study

Axel Grothey, Kim Jordan, O Kellner et al. · Journal of Clinical Oncology · 2004 · 40 citations

Line Capiri, Surgery, Pharmacotherapy +20

Phase II Trial of Capecitabine/Irinotecan and Capecitabine/Oxaliplatin in Advanced Gastrointestinal Cancers

Karin Jordan, O Kellner, Thomas Kegel et al. · Clinical Colorectal Cancer · 2004 · 36 citations

Phase Ii Trial, Gastrointestinal Oncology, Medicine +7